GSE100148 EZH2 inhibition 8 v 5 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE100148_EZH2 inhibition_8_v_5_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE100148_EZH2 inhibition_8_v_5_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE100148_EZH2 inhibition_8_v_5_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE100148_EZH2 inhibition_8_v_5_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

valyl-tRNA synthetase 1

Gene

WD repeat domain 46

Gene

small nucleolar RNA host gene 3

Gene

H2A clustered histone 19

Gene

small nucleolar RNA host gene 4

Gene

MIR1915 host gene

Gene

leukocyte receptor cluster member 9

Gene

CENPB DNA-binding domains containing 2, pseudogene

Gene

TALAM1 transcript, MALAT1 antisense RNA

Gene

TGF-beta induced TARBP2 interacting lncRNA

  • Gene

    valyl-tRNA synthetase 1


  • Gene

    WD repeat domain 46


  • Gene

    small nucleolar RNA host gene 3


  • Gene

    H2A clustered histone 19


  • Gene

    small nucleolar RNA host gene 4



  • Gene

    leukocyte receptor cluster member 9


  • Gene

    CENPB DNA-binding domains containing 2, pseudogene


  • Gene

    TALAM1 transcript, MALAT1 antisense RNA


  • Gene

    TGF-beta induced TARBP2 interacting lncRNA

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.